Molecular Subtypes of Diffuse Large B-cell Lymphoma
Molecular Subtypes of Diffuse Large B-cell Lymphoma
Continuing Education Credit is no longer available for this course.
Description:
This presentation will outline molecular subtypes of diffuse large B-cell lymphoma (DLBCL), including those recognized by the latest classifications and those that are emerging and close to the clinic. The subtypes will be described, along with their clinical relevance and the challenges to implement appropriate assays in the laboratory. Finally, the evolution of DLBCL from diagnosis to relapse will be outlined with implications for molecular testing and our understanding of disease biology and patient management.
Learning Objectives:
- Recognize the
molecular subtypes of DLBCL within the WHO HAEM5 and ICC classifications and
describe the key differences between these schema.
- Understand the
origin and biology of the recently described dark zone lymphomas.
- Illustrate the challenges of implementing appropriate assays for assigning genetic subtypes of DLBCL.
 |
 |
|---|---|
| Speaker: David W Scott; MBChB,
PhD |
Moderator: Jennifer Bynum, MD Northside Hospital and Laboratories |
Level of Instruction: Intermediate
Date Recorded: August 3, 2023
Planned and coordinated by the Training and Education Committee
Continuing Education Credit Information
Continuing Education Credit is no longer available for this course.Note: Members of AMP can access this webinar at no cost. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.